Cantel Medical Q4 Conference Call highlights

Cantel Medical

reported its fourth quarter earnings on Monday. Shares of the company are up 2%. Below are some key highlights from its conference call: • We reported fourth quarter earnings of $0.26 per share which included $0.02 of charges for acquisitions • CFO retirement costs as compared to the prior year's fourth quarter earnings of $0.25 per share. • This quarter's adjusted EPS growth was 14% ahead of the same quarter last year. • Sales increased 15% in the quarter of which 13% was organic. • Adjusted EPS for the full year increased from $0.94 to $1.07. • Which followed our stellar performance in fiscal year 2013 where EPS grew by 23%. EBITDAS for the year grew by 13.5% to $95.7 million. • Positioned Cantel for continued growth in fiscal year 2015 and beyond by successfully integrating our recent acquisitions. • In this quarter, we recorded sales of $55 million which are up 23% from the prior year's quarter of which 20% was organic. • Prior year quarter was a record which last quarter was $47.3 million, so nice growth. • $2 million of this came from success in winning a large tender in Eastern Europe. • Operating profit for this segment on a reported basis increased 17%; but after adjusting for acquisition cost related to PuriCore in the quarter, operating profits grew by 25%. • International sales of our endoscopy products grew by 62% in the fourth quarter and were up 39% for the full fiscal year. • This quarter, the segment's performance was excellent and led the overall growth and profitability for Cantel. • Sales of $40.8 million grew by 14% over the same quarter last year, with organic growth of 11% for the quarter. • Our Crosstex Healthcare Disposables business continues to be a solid performer with sales this quarter of $25.3 million, up 6% over the same quarter last year. • Operating profits for this segment were down 13% or about $600,000. • Further, we are well under way with an extensive strategic restructuring of our U.S. sales and marketing approach to drive growth in the changing dental market. • Operating profit increased 2% due to higher volumes. • Gross profit for the third quarter was 43.4 - for the fourth quarter was 43.4% compared with 43.1% last year in the fourth quarter. And for the full year. • Overall, reporting a $1.5 million or 9% increase in operating income for the fourth quarter. • Total interest expense is now running at only about $500,000 per quarter. • Effective rate is 36.9% for fiscal 2014,